News Daily News Ezetimibe Fails to Garner Support for CV- Event Reduction Claim From FDA Advisory Committee Michael O'Riordan December 15, 2015
News Industry News Novartis provides update on EU marketing authorization application for RLX030 in acute heart failure May 23, 2014